Lianyungang, China

Shenggang Fan

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Lianyungang Jinkang Hexin Pharmaceutical Co., Ltd.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shenggang Fan. Retrieved from https://idiyas.com/inventor/shenggang-fan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Shenggang Fan in Pharmaceutical Development

Introduction

Shenggang Fan is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on compounds that can be utilized in drug development.

Latest Patents

One of Shenggang Fan's key patents is for the compound JK12A, which is described as [4-(2-amino-10-methyl-4-oxo-6,7,8,9-tetrahydro-4a,7-cycloimino-pyrimido[4,5-b][1,4]diazepine-5(4H)-yl)benzoyl]-glutamate. This compound has various applications, including its use as an active ingredient in medicaments and food additives. The patent also covers the crystal form and salt of JK12A, along with its preparation methods.

Career Highlights

Shenggang Fan is associated with Lianyungang Jinkang Hexin Pharmaceutical Co., Ltd., where he continues to work on innovative pharmaceutical solutions. His expertise in compound development has positioned him as a valuable asset in the industry.

Collaborations

Shenggang Fan has collaborated with notable colleagues, including Yongzhi Cheng and Zhi Cheng, to further advance research and development in pharmaceuticals.

Conclusion

Shenggang Fan's contributions to the field of pharmaceuticals, particularly through his patent for JK12A, highlight his innovative spirit and dedication to improving drug development. His work continues to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…